Glucagon like peptide-1 receptor agonists and the risk of anaphylactic reactions among patients with type 2 diabetes
- Resource Type
- Journal
- Source
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY ; OCT 2020, 29 p594-p594, 1p. Supplement: 3- Subject
- Language
- English
- ISSN
- 10991557